JZP-386

N/A

Report date: 2025/02/28 11:25:14
NME

Base Information

Drug NameJZP-386
Drug Alias NameDeuterated sodium oxybateSodium oxybate deuteratedDeuterium modified sodium oxybateC-10323JZP-386
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Deuterated drugs
Mechanisms of ActionDopamine receptors agonists
TargetsDopamine receptors
Therapy Area/IndicationsNarcolepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesConcert
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesConcertJazz Pharmaceuticals Plc
Active IndicationsN/A
Inactive IndicationsNarcolepsy

Other Information

ATC CodeN/A
Related LinksN/A